Fabrazyme Related Clinical Trials
A Study in Patients With Fabry Disease Who Are on Chronic Hemodialysis Therapy for Treatment of End-Stage Renal Insufficiency. [Terminated]
A Study of Two Fabrazyme (Agalsidase Beta) Dosing Regimens in Treatment-naïve, Male Pediatric Patients Without Severe Symptoms [Recruiting]
A Study of the Effects of Fabrazyme (Agalsidase Beta) on Mother's Lactation and on the Growth, Development and Immunologic Response of Their Infants [Recruiting]
A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease [Completed]
A Long Term Safety and Efficacy Study of Fabrazyme Replacement Therapy in Japanese Patients With Fabry Disease. [Recruiting]
A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease [Completed]
A Study of the Safety and Efficacy of Fabrazyme as Compared to Placebo in Patients With Advanced Fabry Disease [Completed]
A Study of Fabrazyme in Pediatric Patients With Fabry Disease [Completed]
A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease [Completed]
A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease [Recruiting]
Dosing Study of Replagal in Patients With Fabry Disease [Active, not recruiting]
Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry Disease [Recruiting]
The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study [Recruiting]
The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease [Recruiting]
Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta [Recruiting]
Canadian Fabry Disease Initiative (CFDI) Enzyme Replacement Therapy (ERT) Study [Recruiting]
Study to Compare the Efficacy and Safety of Oral AT1001 and Enzyme Replacement Therapy in Patients With Fabry Disease [Recruiting]
Fabry Disease Registry [Recruiting]
Pulmonary Disease and Exercise Tolerance in Boys With Fabry Disease [Recruiting]
Drug-Drug Interaction Study Between AT1001 and Agalsidase in Subjects With Fabry Disease [Recruiting]
Antiproteinuric Agents and Fabry Disease [Completed]
|
